Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-25-000223

Chief Financial Officer gave up 2,775 shares (to pay taxes)

  • Chief Financial Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Adams Kendra · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-18 Exercise or conversion : show line 1 in the form +6,250 165,117 D
2025-09-18 Shares withheld for taxes : show line 2 in the form −2,775 $3.32 $9,213 162,342 D
Loading xslF345X05/wk-form4_1758312827.xml…